# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000200406-24-000049
Filing Date
2024-05-01
Accepted
2024-05-01 07:09:36
Documents
93
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | jnj-20240331.htm iXBRL | 10-Q | 1900232
2 | EX-31.1 | a20241qex311ceocertificati.htm | EX-31.1 | 8440
3 | EX-31.2 | a20241qex312cfocertificati.htm | EX-31.2 | 8400
4 | EX-32.1 | a20241qex321ceocertificati.htm | EX-32.1 | 4690
5 | EX-32.2 | a20241qex322cfocertificati.htm | EX-32.2 | 4569
11 |  | jnj-20240331_g1.jpg | GRAPHIC | 24354
12 |  | jnj-20240331_g2.jpg | GRAPHIC | 32440
13 |  | jnj-20240331_g3.jpg | GRAPHIC | 22966
14 |  | jnj-20240331_g4.jpg | GRAPHIC | 14772
15 |  | jnj-20240331_g5.jpg | GRAPHIC | 14959
16 |  | jnj-20240331_g6.jpg | GRAPHIC | 15869
17 |  | jnj-20240331_g7.jpg | GRAPHIC | 16070
18 |  | jnj-20240331_g8.jpg | GRAPHIC | 17027
| Complete submission text file | 0000200406-24-000049.txt |  | 11409793

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | jnj-20240331.xsd | EX-101.SCH | 68166
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | jnj-20240331_cal.xml | EX-101.CAL | 93489
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | jnj-20240331_def.xml | EX-101.DEF | 326180
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | jnj-20240331_lab.xml | EX-101.LAB | 847502
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | jnj-20240331_pre.xml | EX-101.PRE | 565711
96 | EXTRACTED XBRL INSTANCE DOCUMENT | jnj-20240331_htm.xml | XML | 2202039

Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 10-Q | Act: 34 | File No.: 001-03215 | Film No.: 24900037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)